| Date Filed | Type | Description |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Lippa Arnold (Exec. Chairman & CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 100 options to buy
@ $0.0064, valued at
$0.6
Gifted 100 options to buy
@ $0.0064, valued at
$0.6
Gifted 100 options to buy
@ $0.0064, valued at
$0.6 |
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2020 |
4
| Margolis Jeff Eliot (SVP, CFO, Secretary & Teasurer) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 4,500,000 shares
@ $0
Gifted 4,250,000 shares
@ $0
Gifted 4,250,000 shares
@ $0
Gifted 125,000 shares
@ $0
Gifted 125,000 shares
@ $0
Gifted 125,000 shares
@ $0 |
|
| 03/24/2020 |
4
| Lippa Arnold (Exec. Chairman, CEO, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 4,500,000 shares
@ $0
Gifted 4,500,000 shares
@ $0 |
|
| 09/14/2018 |
4
| Lippa Arnold (Exec Chairman, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Bought 47,620 shares
@ $0
Gifted 47,620 shares
@ $0
Bought 47,620 warrants
@ $1.575, valued at
$75k
Gifted 47,620 warrants
@ $1.575, valued at
$75k
|
|
| 12/12/2017 |
4
| MacFarlane Katie (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 38,114 options to buy
@ $1.45, valued at
$55.3k
|
|
| 12/12/2017 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 38,114 options to buy
@ $1.45, valued at
$55.3k
|
|
| 12/12/2017 |
4
| Lippa Arnold (Exec Chairman, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 559,595 options to buy
@ $1.45, valued at
$811.4k
Gifted 559,595 options to buy
@ $1.45, valued at
$811.4k
|
|
| 12/12/2017 |
4
| Purcell Richard David Jr. (SVP - Research and Development) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.45, valued at
$145k
|
|
| 12/12/2017 |
4
| MANUSO JAMES S J (President and CEO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Bought 1,097 shares
@ $0
Bought 2,195 warrants
@ $0
Acquired 608,704 options to buy
@ $1.45, valued at
$882.6k
|
|
| 12/12/2017 |
4
| Margolis Jeff Eliot (SVP, Treas., Sec., CFO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 388,687 options to buy
@ $1.45, valued at
$563.6k
Gifted 250,000 options to buy
@ $1.45, valued at
$362.5k
Gifted 250,000 options to buy
@ $1.45, valued at
$362.5k
Gifted 100,000 options to buy
@ $1.45, valued at
$145k
Gifted 100,000 options to buy
@ $1.45, valued at
$145k
Gifted 38,687 options to buy
@ $1.45, valued at
$56.1k
Gifted 38,687 options to buy
@ $1.45, valued at
$56.1k
Gifted 38,687 options to buy
@ $1.45, valued at
$56.1k
|
|
| 07/28/2017 |
4
| Margolis Jeff Eliot (SVP, CFO, Sec. & Treasurer) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 25,000 options to buy
@ $2, valued at
$50k
|
|
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Margolis Jeff Eliot (VP, Treasurer and Secretary) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $2, valued at
$60k
Granted 20,000 options to buy
@ $2, valued at
$40k
|
|
| 07/05/2017 |
4
| Lippa Arnold (Executive Chairman & CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 50,000 options to buy
@ $2, valued at
$100k
Disposed of 50,000 options to buy
@ $2, valued at
$100k
|
|
| 07/05/2017 |
4
| MacFarlane Katie (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 25,000 options to buy
@ $0 |
|
| 07/05/2017 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 25,000 options to buy
@ $2, valued at
$50k
|
|
| 07/05/2017 |
4
| MANUSO JAMES S J (President and CEO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Granted 50,000 options to buy
@ $2, valued at
$100k
|
|
| 01/20/2017 |
4
| Purcell Richard David Jr. (SVP - Research and Development) has filed a Form 4 on RespireRx Pharmaceuticals Inc. |
| 01/20/2017 |
4
| MacFarlane Katie (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc. |
| 01/20/2017 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc. |
| 01/20/2017 |
4
| Lippa Arnold (Executive Chairman and CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc. |
| 01/20/2017 |
4
| WEINGARTEN ROBERT N (EVP & CFO) has filed a Form 4 on RespireRx Pharmaceuticals Inc. |
| 01/20/2017 |
4
| MANUSO JAMES S J (Preident & CEO) has filed a Form 4 on RespireRx Pharmaceuticals Inc. |
|